![]() |
市场调查报告书
商品编码
1541542
透明质酸原料市场报告按应用(眼科、骨科、皮肤科、药物传输、医疗器械涂层、手术粘连预防、生物材料和植入物、细胞和组织保存)和地区2024-2032Hyaluronic Acid Raw Material Market Report by Application (Ophthalmology, Orthopedics, Dermatology, Drug Delivery, Medical Device Coating, Surgical Adhesion Prevention, Biomaterials and Implants, Cell and Tissue Preservation), and Region 2024-2032 |
IMARC Group年全球透明质酸原料市场规模达71亿美元。
透明质酸原料是用来製造天然化合物的物质。这种酸天然存在于眼睛、头髮、关节、神经、软骨和皮肤细胞外基质中。也可由小麦蛋白胨、糖和某些细菌发酵合成。这些成分有助于支持结缔组织的功能,并透过增加蛋白质和调节皮肤中的水分浓度来促进胶原蛋白结合。局部应用酸可以帮助皮肤再生并减少发炎。因此,它在化妆品、药物传输系统、药品和营养补充剂的製造中广泛使用。
全球製药业的显着成长是创造积极市场前景的关键因素。透明质酸作为黏弹性和抗手术黏附剂,广泛用于眼科、皮肤科和骨科手术,作为组织黏附的机械屏障。此外,大众对抗皱和抗衰老面霜以及美容增强解决方案的需求不断增长,也推动了市场成长。此外,各种技术进步,例如标靶药物传递和再生医学创新解决方案的开发,也是其他生长诱导因素。医疗保健提供者广泛使用透明质酸注射来提供润滑、减少发炎并促进关节中的软骨和骨骼生长。其他因素,包括消费者支出能力的提高以及广泛的研发(R&D)活动,预计将推动市场成长。
The global hyaluronic acid raw material market size reached US$ 7.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.8 Billion by 2032, exhibiting a growth rate (CAGR) of 5.7% during 2024-2032.
Hyaluronic acid raw materials are the substances used for the manufacturing of the natural compound. The acid is naturally present in the eyes, hair, joints, nerves, cartilages and extracellular matrix in the skin. It can also be synthesized by fermenting wheat peptones, sugar and certain bacteria. These ingredients aid in supporting the functioning of the connective tissues and promoting collagen binding by building up the proteins and regulating water concentration in the skin. The topical application of the acid can assist in the regeneration of the skin and reduce inflammation. As a result, it finds extensive applications in the manufacturing of cosmetics, drug delivery systems, pharmaceuticals and nutritional supplements.
Significant growth in the pharmaceutical industry across the globe is of the key factors creating a positive outlook for the market. Hyaluronic acid acts as a viscoelastic and anti-surgical adhesion agent, which is widely used in ophthalmic, dermatological and orthopedic procedures as a mechanical barrier for tissue adherence. Moreover, the increasing demand for anti-wrinkle and anti-aging creams and solutions among the masses for cosmetic enhancements is providing a thrust to the market growth. Additionally, various technological advancements, such as the development of innovative solutions for targeted drug delivery and regenerative medicines, are acting as other growth-inducing factors. Healthcare providers are extensively using hyaluronic acid injections to provide lubrication, reduce inflammation and promote cartilage and bone growth in the joint. Other factors, including rising expenditure capacities of the consumers, along with extensive research and development (R&D) activities, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global hyaluronic acid raw material market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on application.
Ophthalmology
Cataract Surgery
Aqueous Eye Drop
Contact Lens
Orthopedics
Viscosupplements
Bone Regeneration
Dermatology
Intradermal
Dermal Filler
Wound Healing
Drug Delivery
Medical Device Coating
Surgical Adhesion Prevention
Biomaterials and Implants
Cell and Tissue Preservation
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Anika Therapeutics Inc., Contipro a.s., Galderma S.A., LG Chem Ltd., Lifecore Biomedical LLC (Landec Corporation), Sanofi S.A., Seikagaku Corporation, Smith & Nephew plc and Zimmer Biomet.